News Center
-
C-RAY Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital
In November 2024, C-RAY Therapeutics (Chengdu) Co., Ltd. (hereinafter referred to as "C-RAY"), an innovative enterprise in the field of radiopharmaceuticals, announced the completion of its Series A+ financing round exceeding $100 million.
넶16 2025-06-16 -
Join Us at SNMMI 2025 in New Orleans!
Visit Us at SNMMI 2025 in New Orleans: Booth #2128
넶8 2025-06-16